Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas

NCT00089089 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

42

Enrollment

NIH

Sponsor class

Conditions

Hematopoietic/Lymphoid Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: decitabine
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)